Dual EGFR/HER2 Blockade Combined With Irinotecan for the Treatment of HER2-Positive Metastatic Colorectal Cancer
Clinical trial NCT07059338 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07059338
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-11
- Primary completion
- 2027-12-30
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.